Related Experiment Video
Updated: May 21, 2026
07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Carboplatin-induced hypersensitivity reaction.
Evangelos Potolidis1, Charalampos Mandros
1Department of Internal Medicine, Volos General Hospital, Volos, Greece.
Case Reports in Oncology
|June 6, 2012
Summary
A patient with relapsing ovarian cancer experienced a severe hypersensitivity reaction to carboplatin, leading to critical respiratory and circulatory complications. This case highlights the potential for severe adverse events during chemotherapy for ovarian cancer.
Area of Science:
- Oncology
- Clinical Pharmacology
- Critical Care Medicine
Background:
- Ovarian cancer is a leading cause of cancer-related mortality in women.
- Carboplatin is a widely used platinum-based chemotherapy agent for ovarian cancer.
- Hypersensitivity reactions (HSRs) to platinum agents can occur, necessitating careful monitoring.
Observation:
- A 65-year-old female patient with relapsed ovarian cancer was treated with carboplatin.
- During the second cycle of carboplatin, the patient exhibited signs of a severe hypersensitivity reaction.
- The reaction manifested as respiratory failure, acute respiratory distress syndrome (ARDS), and hypotension.
Findings:
- The patient required intensive care unit (ICU) admission due to the severity of the reaction.
- This case underscores the potential for life-threatening HSRs to carboplatin, even after initial tolerance.
- Prompt recognition and management of HSRs are crucial in patients receiving platinum-based chemotherapy.
Implications:
- Clinicians should maintain a high index of suspicion for HSRs to carboplatin in ovarian cancer patients.
- Management strategies for severe HSRs to carboplatin may involve immediate discontinuation and supportive care.
- Further research into predictive markers and desensitization protocols for carboplatin HSRs is warranted.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...